Poster presentation details are below: Author: Molina et al Title: CID-078, a first-in-class oral cyclin A/B-RxL inhibitor, elicits anti-tumor activity in breast cancer patient-derived xenograft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback